UK

Pharma given COVID-19 test ‘call to arms’ by UK health secretary
Pharma given COVID-19 test ‘call to arms’ by UK health secretary
Pharmaforum
UK
drug development
COVID-19
pandemic
Flag link:
GSK, AstraZeneca in talks for joint U.K. COVID-19 diagnostics project: Bloomberg
GSK, AstraZeneca in talks for joint U.K. COVID-19 diagnostics project: Bloomberg
Fierce Biotech
GSK
AstraZeneca
UK
diagnostics
COVID-19
Flag link:
AstraZeneca's HQ budget balloons to 3 times original forecast
AstraZeneca's HQ budget balloons to 3 times original forecast
Fierce Biotech
AstraZeneca
headquarters
UK
Flag link:
Pharma industry body urges “ambition” in UK-EU trade talks
Pharma industry body urges “ambition” in UK-EU trade talks
Pharmaforum
trade
UK
Europe
ABPI
Flag link:
U.K. Regulatory Advisor Rejects Roche Cancer Drug
U.K. Regulatory Advisor Rejects Roche Cancer Drug
Motley Fool
Roche
UK
NICE
Polivy
cancer
Flag link:
GW Pharma tops list of UK R&D spenders
GW Pharma tops list of UK R&D spenders
Pharmaforum
GW Pharma
UK
R&D
Flag link:
Life Sciences Jobs Expected to Grow by 133,000 Over Next 10 Years in the U.K.
Life Sciences Jobs Expected to Grow by 133,000 Over Next 10 Years in the U.K.
BioSpace
life sciences
jobs
UK
devices
Medtech
biopharma
Flag link:
Novartis plots cardio trial in UK as London HQ opens
Novartis plots cardio trial in UK as London HQ opens
Pharmaforum
Novartis
clinical trials
London
UK
inclisiran
Flag link:
NICE shuns Novo Nordisk's obesity med Saxenda, citing CV questions
NICE shuns Novo Nordisk's obesity med Saxenda, citing CV questions
Fierce Pharma
Novo Nordisk
Saxenda
UK
NICE
Flag link:
Amid U.K. cutbacks, AstraZeneca plows $520M into manufacturing and R&D in France
Amid U.K. cutbacks, AstraZeneca plows $520M into manufacturing and R&D in France
Fierce Pharma
AstraZeneca
R&D
France
Brexit
UK
drug manufacturing
Flag link:
Tumour-agnostic drugs ‘game-changing’, says NICE as it rejects one from Bayer
Tumour-agnostic drugs ‘game-changing’, says NICE as it rejects one from Bayer
Pharmaforum
cancer
UK
NICE
Bayer
Vitrakvi
drug pricing
Flag link:
Despite secret discount, Roche's Tecentriq hits NICE roadblock in small-cell lung cancer
Despite secret discount, Roche's Tecentriq hits NICE roadblock in small-cell lung cancer
Fierce Pharma
Roche
Tecentriq
NICE
UK
Small-Cell Lung Cancer
Flag link:
The 4 biggest pharma market access stories of 2019
The 4 biggest pharma market access stories of 2019
Pharmaforum
biosimilars
UK
Orkambi
Vertex Pharmaceuticals
drug pricing
FDA
NICE
Flag link:
Could Spark Therapeutics’ merger with Roche finally get the go-ahead?
Could Spark Therapeutics’ merger with Roche finally get the go-ahead?
Pharmaforum
Spark Therapeutics
Roche
UK
M&A
CMA
Flag link:
U.K. government vows to double dementia funding if reelected
U.K. government vows to double dementia funding if reelected
Fierce Biotech
UK
dementia
Flag link:
Secret US-UK talks on drug pricing revealed
Secret US-UK talks on drug pricing revealed
Pharmaforum
UK
Europe
trade
drug pricing
Flag link:
Ranking the Top 10 Biotech Clusters in Europe
Ranking the Top 10 Biotech Clusters in Europe
BioSpace
Europe
biotech
McKinsey
UK
Germany
France
Spain
The Netherlands
Flag link:
After years of battling, Vertex and the U.K. reach a deal for cystic fibrosis medicines
After years of battling, Vertex and the U.K. reach a deal for cystic fibrosis medicines
Stat
Vertex Pharmaceuticals
cystic fibrosis
UK
Flag link:
Eli Lilly to shutter neuroscience R&D center next year
Eli Lilly to shutter neuroscience R&D center next year
Fierce Biotech
Eli Lilly
UK
layoffs
R&D
Flag link:
Clovis' Rubraca, trailing PARP rivals, nabs England coverage thanks to NICE U-turn
Clovis' Rubraca, trailing PARP rivals, nabs England coverage thanks to NICE U-turn
Fierce Pharma
Clovis Oncology
Rubraca
NICE
UK
PARP inhibitors
Flag link:

Pages